期刊文献+

透析治疗的终末期肾病病人血浆网膜素水平及相关因素 被引量:2

Serum levels of omentin in chronic hemodialysis patients and its related factors
原文传递
导出
摘要 [目的]探讨接受血透治疗的终末期肾病(ESRD)病人血浆网膜素水平变化及其与体重指数(BMI)、血清肌酐(Scr)、血糖、血脂、胰岛素抵抗指数的关系。[方法]收集62例ESRD病人(男32人,女30人)资料,同时选取年龄匹配的肾功能正常的健康成人80例做为正常对照组。采用酶联免疫法测定空腹血浆网膜素水平,采用稳态模型评估法(Homa-IR)计算胰岛素抵抗指数,并分析血浆网膜素与BMI、血脂、血糖及Homa-IR等的关系。[结果]ESRD病人血清网膜素水平明显高于正常人(P<0.01),ESRD组伴有糖尿病者网膜素水平又明显低于无糖尿病的病人(P<0.01)。血浆网膜素水平与BMI、Homa-IR呈负相关,与高密度脂蛋白胆固醇、Scr水平呈明显正相关(r=0.424,P<0.01)。[结论]ESRD病人血浆网膜素水平较健康者升高,ESRD病人合并糖尿病者血浆网膜素水平较未合并糖尿病病人低。 Objective] To investigate plasma level of omentin in chronic hemodialysis patients and its correlation with BMI,serum creatinine,fasting glucose,blood lipid and Homa-IR. [Methods] The study included 80 health people as control group and 62 chronic hemodialysis patients .A double antibody sandwich enzyme-linked immuno sorbent assay ( ELISA ) method was applied to detect the level of serum omentin and homeostasis model assessment of insulin resistant ( Homa-IR) to assess the insulin resistance index ,analysis being done on correlation between serum omentin and other indexes . [ Results ] The levels of plasma omentin was significantly higher in hemodialysis patients than those in control group ( P〈0.01).ESRD(end-stage renal disease) patients with diabetes had lower level of plasma omentin than those without diabetes .The serum level of omentin had negative correlation with BMI and Homa-IR, and positive correlation with HDL-C, serum creatinine . [ Conclusion] The serum level of omentin proves to be ele-vated in ESRD patients receiving hemodialysis;and those with diabetes had lower levels of plasma omentin than those without .
出处 《上海预防医学》 CAS 2015年第5期295-297,共3页 Shanghai Journal of Preventive Medicine
关键词 网膜素 终末期肾病 糖尿病 Omentin End-stage renal disease (ESRD) Diabetes
  • 相关文献

参考文献11

  • 1VANHOLDER R, MASSY Z, ARGILES A, et al : Chronic kidney diseaseas cause of cardiovascular morbidity and mortality[ J ]. Nephrol Dial Transplant, 2005,20 : 1048 - 1056.
  • 2RODRLGUEZ - HERNDNDEZ H', SIMENTAL - MENDFA LE, RODRIGUEZ - RAMTREZ G, et al. Obesity and inflam- mation : epidemiology, risk factors, and markers of inflamma- tion[ JJ. Int J Endocrinol,2013 ,2013 :578159.
  • 3ABDALLAH E, WAKED E, NABIL M, et al. Adiponectin and cardiovascular outcomes among hemodialysis patients [ J ]. Kidney Blood Press Res,2012,35:247 - 253.
  • 4AXELSSON J, STENVINKEL P. Role of fat mass and adipo- kines in chronic kidney disease [ J ]. Curr Opin Nephrol Hy- pertens ,2008,17:25 - 31.
  • 5TASKAPAN M C, TASKAPAN H, SAHIN I, et al. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality [ J ]. Ren Fail, 2007,29 : 147 - 154.
  • 6YAMAWAKI H, KURAMOTO J, KAMESHIMA S, et al. Omentin, a novel adipocytokine inhibits TNF- induced vascular inflammation in human endothelial cells [ J ]. Bio- chem Biophys Res Commun ,2011,408 (2) :339 - 343.
  • 7TRIPEPI G, MATrACE RASO F, SIJBRANDS E, et al. Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients [ J ]. Clin J Am Soc Nephrol,2011,6:1714 - 1721.
  • 8SHINOHARA K, SHOJI T, EMOTO M, et al. Insulin resist- ance as an independent predictor of cardiovascular mortality in patients with end- stage renal disease[ J ]. J Am Soc Nephrol 2002,13:1894 - 1900.
  • 9MORENO - NAVARRETE J M, ORTEGA F,et al. Circulat- ing omentin as a novel biomarker of endothelial dysfunction [ J]. Obesity,2011,19 : 1552 - 1559.
  • 10TAN B K, PUA S, SYED omentin - 1 levels in type 1 F, et al. Decreased plasma diabetes mellitus [ J ]. Diabet Med,2008,25 : 1254 - 1255.

同被引文献28

  • 1Simó VE,Jiménez AJ,Oliveira JC,et al. Efficacy of neuromuscularelectrostimulation intervention to improve physical function inhaemodialysis patients[J]. Int Urol Nephrol,2015,47(10):1709-1717. doi:10.1007/s11255-015-1072-3.
  • 2Torino C,Manfredini F,Bolignano D,et al. Physical performanceand clinical outcomes in dialysis patients:a secondary analysis ofthe EXCITE trial[J]. Kidney Blood Press Res,2014,39(2/3):205-211. doi:10.1159/000355798.
  • 3Peres A,Perotto DL,Dorneles GP,et al. Effects of intradialyticexercise on systemic cytokine in patients with chronic kidneydisease[J]. Ren Fail,2015,37(9):1430- 1434. doi:10.3109/0886022X.2015.1074473.
  • 4Groussard C,Rouchon- Isnard M,Coutard C,et al. Beneficialeffects of an intradialytic cycling training program in patients withend-stage kidney disease[J]. Appl Physiol Nutr Metab,2015,40(6):550-556. doi:10.1139/apnm-2014-0357.
  • 5Kocijancic M,Vujicic B,Racki S,et al. Serum omentin-1 levels asa possible risk factor of mortality in patients with diabetes onhaemodialysis[J]. Diabetes Res Clin Pract,2015,110(1):44-50.doi:10.1016/j.diabres.2015.06.008.
  • 6Manfredini F,Lamberti N,Malagoni AM,et al. The role ofdeconditioning in the end-stage renal disease myopathy:physicalexercise improves altered resting muscle oxygen consumption[J].Am J Nephrol,2015,41(4/5):329-336. doi:10.1159/000431339.
  • 7Wang ZG. Blood Purification[M]. Version 2. Beijing:BeijingScience and Technology Press,2003:612-616.
  • 8Kopple JD,Kim JC,Shapiro BB,et al. Factors affecting daily physicalactivity and physical performance in maintenance dialysis patients[J].Ren Nutr,2015,25(2):217-222. doi:10.1053/j.jrn.2014.10.017.
  • 9Jeong JH,Wu PT,Kistler BM,et al. The presence and impact ofdiastolic dysfunction on physical function and body composition inhemodialysis patients[J]. J Nephrol,2015,28(6):739-747. doi:10.1007/s40620-015-0188-y.
  • 10Bae YH,Lee SM,Jo JI. Aerobic training during hemodialysisimproves body composition,muscle function,physical performance,and quality of life in chronic kidney disease patients[J]. J PhysTher Sci,2015,27(5):1445-1449. doi:10.1589/jpts.27.1445.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部